Frenova, a company of Fresenius Medical Care North America (FMCNA), with its team of renal research experts, operates at the convergence of clinical research and renal patient care. No other clinical development services provider works with a more intimate understanding of patients affected by kidney disease and its comorbid conditions than we do. Whether you want to conduct a renal-related study, need guidance on your protocol or access to patients, start with the patient in mind — and trust the partner that’s completely renal.
Today, Frenova manages the world’s largest network of renal research assets, including over 450 principal investigators at more than 260 sites representing 160 medical practices and nearly 700 dialysis clinics. We also offer access to nearly 200,000 active ESRD patients and hundreds of thousands of active CKD patients. By pairing this extensive network with our clinical development and bioinformatics database and capabilities, Frenova assesses your protocol feasibility, drives patient recruitment/enrollment strategies and identifies the right sites for your study. We’re committed to developing strategies that shorten your path to study completion no matter the scope of your study needs.
- Studies involving clinical variables and clinical outcomes
- Defining best practices
- Defining clinical problems
- Exploring clinical targets
- Elucidating outcomes associated with clinical algorithms
- Clinical processes/practices, medications